A partnership between MSD and Sanofi Pasteur inc. to offer an hexavalent pediatric vaccine.
Sanofi has been a leader in vaccines for more than 100 years.
The combination of our innovative vaccines and global reach means that many diseases do not hold the power they once did. Our determination to improve public health motivates us to develop new vaccines to address still unmet medical needs. Fueled by new data and digital technologies, our science and manufacturing have the potential to transform the practice of medicine for millions of people around the world.
For more information, visit Sanofi.com
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world's most challenging diseases.
MSD is a trade name of Merck & Co., Inc., with headquarters in Rahway, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions.
We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
For more information, visit www.msd.com and connect with us on Twitter.
A partnership between MSD and Sanofi Vaccines to offer an hexavalent pediatric vaccine.